SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 63 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
| BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
| NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
| Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
| Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
| Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
| Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
| Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |